Vaccines

Moderna defended the use of its Covid-19 vaccine Thursday, saying the protection it offers against severe disease, hospitalization and death outweighs the risk of myocarditis, a rare heart condition seen in a small number of young men who received the shot.

The company announced last week that the Food and Drug Administration needed more time to decide whether to authorize its two-dose vaccine for use in children ages 12 to 17 as the agency looks into reports of myocarditis, or the inflammation of the heart muscle. ...

Country / Region Tags:

Global

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

If cleared by the FDA, monoclonal antibodies could be given to the immunocompromised via injections before exposure to the coronavirus.

Wed, 2021-11-10 12:40 — mike kraft

...

Many immunocompromised Americans, including people with cancer, autoimmune disorders and transplanted organs, are impatiently awaiting what could be their ticket back to some semblance of normalcy: the ability to receive periodic injections of long-acting monoclonal antibodies. This, research suggests, could provide them the substantial protection against Covid-19 that in their cases vaccination may not.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

EU to decide on Moderna's COVID-19 shot for younger kids in two months

Wed, 2021-11-10 10:13 — mike kraft

EU to decide on Moderna's COVID-19 shot for younger kids in two months The European Union's drug regulator expects to decide in about two months on whether to allow the use of Moderna's COVID-19 vaccine in children aged six to 11 years, it said on Wednesday, after the U.S. drugmaker sought approval. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU to decide on Moderna's COVID-19 shot for younger kids in two months
Log in or register to post comments

German advisory committee recommends only Biontech/Pfizer vaccine for under-30s

Wed, 2021-11-10 10:09 — mike kraft

BERLIN, Nov 10 (Reuters) - People aged under 30 in Germany should only receive the Biontech/Pfizer (PFE.N)COVID-19 vaccine as it causes fewer heart inflammations in younger people than the Moderna (MRNA.O)shot, an advisory committee said on Wednesday.

The committee, known as STIKO, recommended that pregnant women also be inoculated only with the Biontech/Pfizer vaccine, regardless of their age.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about German advisory committee recommends only Biontech/Pfizer vaccine for under-30s
Log in or register to post comments

US to provide J&J vaccine for conflict zones

Wed, 2021-11-10 09:44 — mike kraft

Blinken: US to give J&J vaccine in conflict zones Secretary of State Antony Blinken on Wednesday announced an effort to distribute Johnson & Johnson’s COVID-19 vaccines to populations living in conflict zones. Laura Kelly TheHill

...

Blinken said the U.S. has helped broker a deal between Johnson & Johnson and COVAX, the global initiative for distributing the COVID-19 vaccine, to deliver the one-shot J&J vaccine to people living in conflict zones and other humanitarian settings. ...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?: